Trialsgram
beta
RCTs are beautiful
⚄
★
0
EN
⚙
View
COVID-19
1 trial
2022
EPIC-HR
Outpatient antiviral
In
2,246 high-risk unvaccinated adults with COVID-19
,
nirmatrelvir-ritonavir within 5 days of symptom onset
reduced
COVID-19-related hospitalisation or death by day 28
compared with
placebo
.